LIF and gastric cancer: Results were confirmed in the MKN45 GC cell line as well as in PDX cells GC07, GC10 and GC04 (Figure 2A), showing that LIF presents anti-tumorigenic capacities in GC cell lines as well as in cells derived from GC patients.